Item has been added

Get 20% off!arrow_drop_up

Probiotics & Ozempic: Boost GLP-1 and Ease Side Effects

  • person Nicholas Wunder
  • calendar_today
  • comment 0 comments
Woman in her forties in a bright kitchen taking a daily probiotic with water beside fiber-rich whole foods, representing gut health support while managing weight and GLP-1 wellness

Probiotics and Ozempic: How Probiotics and GLP-1 Work Together, According to the Science

What the peer-reviewed research really says about probiotics, GLP-1, and getting the most from your gut while on a GLP-1 medication

If you're taking Ozempic, Wegovy, Mounjaro, or another GLP-1 medication, or just thinking about your gut health in the age of these drugs, you've probably run into a wave of "GLP-1 probiotics" and conflicting advice. Some of it is marketing. Some of it is grounded in real science. This guide separates the two.

Here's the piece most people miss: GLP-1 (glucagon-like peptide-1) isn't just a drug. It's a hormone your own body makes. It's produced by specialized L-cells in your intestine, and one of the most powerful natural triggers for its release is a group of compounds made by your gut bacteria when they ferment fiber.[1] That single fact is why the conversation about your gut microbiome and GLP-1 has become so important.

This article walks through what the clinical and mechanistic research actually shows about probiotics and GLP-1: how gut bacteria influence the hormone naturally, whether probiotics can meaningfully support people on GLP-1 medications, which strains have real evidence behind them, and how to think about fiber, timing, and safety. Throughout, we've cited only peer-reviewed studies, and we're careful to distinguish what's proven in humans from what's still emerging from the lab.

Key Takeaways

  • Your body already makes GLP-1, and your gut bacteria help. Short-chain fatty acids like butyrate, produced when gut microbes ferment fiber, stimulate GLP-1 release from intestinal L-cells through the FFAR2 receptor.[1][2]
  • Probiotics raised GLP-1 in preclinical studies. In animal models, the probiotic formulation VSL#3 increased butyrate-driven GLP-1 secretion and improved glucose tolerance and insulin sensitivity.[3]
  • Probiotics are an adjunct, not a replacement, for GLP-1 medication. A meta-analysis found glucose-lowering drugs outperform probiotics on blood sugar, while probiotics added benefits for lipids and blood pressure.[13]
  • GLP-1 drugs commonly cause constipation, nausea, and bloating. They slow gastric emptying, and in a meta-analysis of nearly 28,000 patients, nausea affected ~21.5% and constipation ~7.9% of users.[7][8] Certain probiotic strains have clinical evidence for constipation relief.[9]
  • Fiber and prebiotics matter even more on a GLP-1. Fermentable fibers feed the butyrate-producing bacteria that drive natural GLP-1 and support regularity. This is exactly what's often lost when appetite (and food volume) drops.
  • Multi-strain formulas without synthetic fillers help ensure the bacteria you're adding aren't working against additives that can disrupt gut health.

GLP-1: The Hormone Your Gut Already Makes

To understand where probiotics fit in, it helps to understand what GLP-1 actually is. Glucagon-like peptide-1 is an incretin, a gut hormone released after you eat. It's produced by enteroendocrine L-cells that line your small and large intestine. Once released, GLP-1 stimulates insulin secretion, slows the rate at which your stomach empties, and signals fullness to your brain. Those are the same effects that make GLP-1 receptor agonist medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) so effective for blood sugar and weight management.

Here's the part that reframes everything: L-cells don't fire at random. They respond to what's happening in your gut, and few signals are more direct than the metabolites your resident bacteria produce. When beneficial microbes ferment dietary fiber, they generate short-chain fatty acids (SCFAs) including acetate, propionate, and butyrate. These SCFAs bind to receptors on L-cells, principally FFAR2 (also called GPR43), and trigger GLP-1 release. In foundational research, GLP-1 secretion was significantly blunted in animals lacking the FFAR2 receptor, pinning down the mechanism directly.[1] Propionate, specifically, was shown to acutely stimulate both GLP-1 and the satiety hormone PYY through the same receptor.[2]

Flowchart showing how dietary fiber is fermented by gut bacteria into short-chain fatty acids that trigger intestinal L-cells to release GLP-1 through the FFAR2 receptor

In other words, a healthy, fiber-fed microbiome is quietly nudging your body's own GLP-1 system every day. This is the biological foundation for everything that follows, and the reason gut health has become central to the GLP-1 conversation.

Can Probiotics Boost GLP-1 Naturally? What the Science Shows

If SCFAs drive GLP-1, and gut bacteria make SCFAs, then a reasonable question follows: can adding beneficial bacteria increase GLP-1? The honest answer is that the mechanism is well established, the preclinical evidence is genuinely encouraging, and the human clinical evidence is still developing. Let's look at each layer.

The mechanism is proven

One of the most-cited studies on this question tested the multi-strain probiotic VSL#3 in mice. The probiotic shifted the gut flora toward greater butyrate production, which in turn stimulated L-cells to secrete more GLP-1, reducing food intake and improving glucose tolerance and insulin sensitivity across several disease models.[3] This is an animal study, so it demonstrates how probiotics can raise GLP-1 rather than proving a specific weight-loss result in people, but it establishes the pathway cleanly: more of the right bacteria means more butyrate, and more butyrate means more GLP-1.

Evidence pyramid summarizing probiotics and GLP-1 research, from proven cell-level mechanisms at the base to promising animal studies and emerging human trials at the top

A separate study in diabetic rats found that a probiotic (and, separately, the polyphenol resveratrol) significantly raised GLP-1 levels and total antioxidant capacity while lowering glucose and insulin resistance.[4] Learning how to naturally increase butyrate and short-chain fatty acids is, in many ways, the practical translation of this research.

Science Spotlight: A 2026 Discovery on Gut Microbes and GLP-1

Researchers at the Cleveland Clinic recently identified a new way gut bacteria influence this system. Certain microbes produce a class of lipids called N-acyl serinols that enhance the body's post-meal GLP-1 and insulin responses, a natural, microbe-driven route to boosting the very hormone that GLP-1 medications target.[5] The work is early and mechanistic, but it points to a future where specific gut bacteria may be leveraged to support metabolic health, and it underscores how much of the GLP-1 story is written in the microbiome.

Could probiotics enhance a GLP-1 medication?

An intriguing 2026 study paired a specific probiotic strain (Limosilactobacillus fermentum GB102) with the GLP-1 drug dulaglutide in mice. The combination produced greater weight loss, blunted the weight regain that often follows treatment, sustained glucose control and, notably, helped prevent the muscle (grip-strength) loss seen with the drug alone.[6] Again, this is preclinical, so it isn't a promise of results in people. But it's a compelling signal that gut bacteria and GLP-1 therapy may be complementary rather than redundant.

What human evidence exists

In people, the strongest human data sits on the metabolic outcomes downstream of GLP-1. A meta-analysis of eight randomized controlled trials found probiotic supplementation reduced HbA1c (a marker of long-term blood sugar) and substantially improved insulin resistance in people with type 2 diabetes.[12] A broader meta-analysis of overweight and obese adults found probiotics produced modest but statistically significant reductions in body weight and BMI.[14] These are real effects, but they are small compared with prescription GLP-1 drugs, which is exactly the point of the next section. If you're exploring the gut-and-metabolism connection more broadly, our overview of probiotics and metabolism and the research on probiotic strains studied for weight loss go deeper.

Support Your Gut's Own GLP-1 Machinery

The bacteria that make butyrate, and the fibers that feed them, are the foundation of natural GLP-1 support. MicroBiome Restore delivers 26 strains plus organic prebiotic fiber in one filler-free daily capsule.

Explore MicroBiome Restore →

Probiotics and Ozempic: Managing GLP-1 Medication Side Effects

For most people taking Ozempic or a similar medication, the more immediate reason to care about probiotics isn't boosting GLP-1. The drug is already doing that powerfully. It's managing the digestive side effects that come with it.

GLP-1 receptor agonists work in part by slowing gastric emptying, which is what prolongs fullness and reduces appetite. But that same slowdown is the source of the most common complaints.[7] In a Bayesian network meta-analysis of 48 randomized trials and nearly 28,000 participants, the dominant gastrointestinal events were nausea (about 21.5%), diarrhea (10.6%), vomiting (9.1%), and constipation (7.9%), with semaglutide carrying one of the highest constipation risks.[8]

Bar chart of common gastrointestinal side effects on GLP-1 medications showing nausea at 21.5 percent, diarrhea 10.6 percent, vomiting 9.1 percent, and constipation 7.9 percent, with a note that probiotics reduced gut transit time by about 12.4 hours

~21.5%experience nausea on GLP-1 drugs[8]
~7.9%experience constipation[8]
~12.4 hrsfaster gut transit with probiotics[9]

Where probiotics come in

This is the area with the most directly relevant human evidence. A systematic review and meta-analysis of randomized controlled trials found that probiotics reduced whole-gut transit time by roughly 12.4 hours and increased stool frequency by about 1.3 bowel movements per week compared with placebo, with Bifidobacterium lactis strains showing the clearest benefit.[9] For anyone dealing with the "why am I so backed up?" reality of a GLP-1, that's meaningful. Our guide to the best probiotics for constipation breaks the strain evidence down further.

For bloating and distension, a large meta-analysis of 82 trials found combination probiotics and Bacillus strains showed benefit, though the authors rated the overall certainty of evidence as low, so this is best framed as "some evidence," not a guarantee.[10] If bloating is your main issue, see our breakdown of probiotics for gas and bloating. And because GLP-1 drugs measurably reshape the gut microbiome, generally increasing beneficial genera like Akkermansia and Lactobacillus while sometimes reducing overall diversity[11], supporting microbial balance during treatment is a reasonable strategy for anyone prone to gut dysbiosis. Mild nausea is also common in the early weeks of a GLP-1.

Important: Probiotics Support, They Don't Replace

Probiotics are not a substitute for your prescribed medication, and they are not a "natural Ozempic." If you're managing type 2 diabetes or obesity, your GLP-1 therapy is doing metabolic work that supplements cannot match. Always talk with your prescribing healthcare provider before adding any supplement, and never adjust your medication on your own. This is especially important if you have a compromised immune system or a serious underlying condition.

Best Probiotic Strains to Pair With GLP-1 Support

Not every probiotic strain is equally relevant here. The strains that matter most for someone thinking about GLP-1 and gut health fall into two buckets: those that support short-chain fatty acid production (the natural GLP-1 pathway) and those with clinical evidence for the digestive complaints GLP-1 drugs tend to cause. Here's how the strains found in MicroBiome Restore map to that research.

SCFA and metabolic-support strains

Bacillus subtilis is a spore-forming strain that survives stomach acid to reach the intestine intact, where it supports short-chain fatty acid production, the same butyrate-and-propionate pathway that stimulates natural GLP-1 release.[1] Lactobacillus plantarum is well studied for intestinal barrier support and metabolic markers, and Lactobacillus fermentum, the genus behind the GLP-1-drug synergy study[6], rounds out this group. Lactobacillus rhamnosus and Lactobacillus gasseri have both been studied in the context of body weight and metabolic health.

Digestive-comfort strains

Bifidobacterium lactis is the standout for regularity, showing the clearest benefit for constipation and gut transit time in the meta-analysis data[9], directly relevant to the most common GLP-1 complaint. Bacillus coagulans is another hardy, spore-forming strain studied for bloating and digestive comfort.

Comparison graphic grouping probiotic strains for GLP-1 users into two categories, SCFA and metabolic support strains like Bacillus subtilis and Lactobacillus fermentum, and digestive comfort strains like Bifidobacterium lactis and Bacillus coagulans

Strain Primary Relevance for GLP-1 Users Evidence Snapshot
Bacillus subtilis Supports SCFA/butyrate production (natural GLP-1 pathway) Spore-former; SCFAs stimulate GLP-1 via FFAR2[1]
Bifidobacterium lactis Constipation & regularity Clearest benefit for gut transit time (meta-analysis)[9]
Bacillus coagulans Bloating & digestive comfort Bacillus strains showed benefit for distension[10]
Lactobacillus fermentum Metabolic support alongside GLP-1 Enhanced GLP-1-drug response in preclinical study[6]
Lactobacillus plantarum Gut barrier & metabolic markers Widely studied for intestinal barrier support
Lactobacillus rhamnosus / gasseri Weight & metabolic health Studied in overweight/obese populations[14]

The through-line is diversity. No single strain covers both the SCFA pathway and every digestive complaint, which is why a broad, multi-strain formula makes more sense here than a single-strain product. Explore the strains in more detail in our complete guide to MicroBiome Restore.

Why Fiber and Prebiotics Matter Even More on a GLP-1

Probiotics get the headlines, but on a GLP-1 medication, prebiotic fiber may be the more urgent piece, for two reasons.

First, fiber is the fuel for the whole natural GLP-1 pathway. Prebiotics are the fermentable fibers your bacteria turn into the short-chain fatty acids that stimulate GLP-1.[1] No fiber, no fermentation, no butyrate. Second, GLP-1 drugs shrink appetite dramatically, which often means people eat far less food overall, and far less fiber specifically. That fiber shortfall is a major driver of the constipation these medications are known for. Deliberately adding prebiotic fiber addresses both problems at once: it feeds the butyrate producers and supports regularity.

Circular diagram showing how prebiotic fibers like inulin, acacia, and maitake feed butyrate-producing gut bacteria, increasing short-chain fatty acids that support natural GLP-1 and digestive regularity

Specific prebiotics worth knowing: inulin, concentrated in Jerusalem artichoke, is one of the most-studied fermentable fibers for feeding Bifidobacterium and boosting SCFA output. Acacia fiber is a gentle, slowly fermented prebiotic that's often better tolerated by sensitive or easily bloated digestive systems, which is useful when a GLP-1 already has your gut feeling temperamental. And beta-glucans from maitake mushroom support both gut and immune function.

The Prebiotic + Probiotic Advantage

MicroBiome Restore is built as a synbiotic: it pairs 26 probiotic strains with 9 organic prebiotics, including Jerusalem artichoke inulin, acacia fiber, maitake mushroom, fig, and mineral-rich sea vegetables. For anyone on a GLP-1 whose fiber intake has quietly dropped, that built-in prebiotic fuel is doing double duty: nourishing the bacteria that support natural GLP-1, and helping keep things moving. If you want the deeper science on how the two work together, see our primer on prebiotics, probiotics, and synbiotics.

What to Look for in a Probiotic if You're on a GLP-1

If you decide to add a probiotic while taking a GLP-1 medication, a few features matter more than usual.

Multi-strain diversity

Because your needs span two categories, SCFA support and digestive comfort, a formula that includes both Lactobacillus and Bifidobacterium species, plus hardy spore-forming Bacillus strains, gives you broader coverage than any single strain. Diversity is the point.

Built-in prebiotics

As covered above, a probiotic that already contains fermentable prebiotic fiber does more for the natural GLP-1 pathway, and for regularity, than probiotics alone.

A clean, filler-free formulation

Many commercial probiotics are padded with inactive ingredients that can work against gut health. Learning to spot the hidden fillers on supplement labels, and choosing clean capsule materials like pullulan capsules, which are fermented and add a small prebiotic benefit of their own, means the bacteria you're introducing aren't fighting the very additives meant to deliver them.

Sensible timing

GLP-1 drugs slow digestion, which can affect how supplements move through you. Most people do well taking a probiotic consistently once a day; our guide on when to take your probiotic covers the details. Consistency matters more than perfect timing.

Checklist: Choosing a Probiotic on a GLP-1

Look for: a multi-strain formula spanning Lactobacillus, Bifidobacterium, and Bacillus; included prebiotic fiber; a meaningful CFU count (10–15 billion or more); a clean, filler-free formulation; and clear strain labeling.

Be cautious of: single-strain products with narrow relevance; "GLP-1 probiotic" marketing that implies drug-like results; proprietary blends that hide individual strain amounts; and formulas padded with synthetic flow agents or fillers.

Is It Safe to Take Probiotics With Ozempic?

For most healthy adults, probiotics are considered safe to take alongside GLP-1 medications, and across dozens of clinical trials they've shown a safety profile comparable to placebo.[10] There's no established drug interaction between standard probiotic strains and semaglutide or other GLP-1 receptor agonists. In fact, because these medications reshape the gut microbiome[11] and commonly cause digestive side effects, supporting gut balance is a sensible complement to treatment for many people.

That said, a few caveats apply. People who are severely immunocompromised, critically ill, or have serious underlying conditions should always check with their doctor before starting a probiotic. And it bears repeating: a probiotic supports your gut. It does not do the metabolic work of your prescribed medication, and it should never be used as a reason to change or stop that medication. The most reliable path is to treat probiotics as one supportive layer within a plan your healthcare provider oversees.

Frequently Asked Questions

Should I take a probiotic while on a GLP-1 medication?

It's a reasonable option for many people, especially if you're experiencing constipation, bloating, or general digestive changes. Probiotics won't replace or replicate your medication, but specific strains have clinical evidence for the exact side effects GLP-1 drugs tend to cause, particularly constipation.[9] Pair the probiotic with adequate fiber and water, and confirm with your prescribing provider first.

What supplements should you not take with Ozempic?

Probiotics are generally considered safe, but the bigger issue with any supplement on a GLP-1 is your provider's oversight. Some supplements can affect blood sugar, blood pressure, or how you tolerate the medication. Be especially cautious with products that make drug-like "natural Ozempic" claims, and always review your full supplement list (including inactive ingredients and fillers) with your healthcare provider rather than stacking products on your own.

Why am I more constipated (or "backed up") on Ozempic?

GLP-1 medications slow gastric emptying and gut motility, which is part of how they curb appetite, but that same slowdown makes constipation one of the most common side effects.[7][8] The drop in appetite also usually means less food and far less fiber, compounding the problem. Adding prebiotic fiber, staying hydrated, and using strains studied for regularity like Bifidobacterium lactis can all help.[9]

Can probiotics really boost GLP-1 like Ozempic does?

Not to the same degree, and it's important to be clear about that. Your gut bacteria genuinely influence your body's natural GLP-1 through short-chain fatty acids, and probiotics raised GLP-1 in animal studies.[1][3] But prescription GLP-1 drugs deliver a far larger, pharmacological effect. Think of probiotics and fiber as supporting your body's own baseline GLP-1 system, not as a replacement for medication.

Do "GLP-1 probiotics" marketed online actually work?

The category is new and largely ahead of the human evidence. The underlying science, that gut bacteria and SCFAs influence GLP-1, is real and well documented.[1][5] But most products marketed specifically as "GLP-1 probiotics" haven't been tested as finished formulas in human trials. A well-formulated multi-strain synbiotic with prebiotic fiber is a more evidence-aligned choice than a product leaning on the "GLP-1" label alone.

The Bottom Line on Probiotics and GLP-1

The science connecting your gut to GLP-1 is real, and it's genuinely elegant: the hormone that today's most talked-about medications mimic is one your own intestine produces every time your bacteria ferment fiber into short-chain fatty acids. Probiotics and prebiotics support that natural system. And for the millions of people taking GLP-1 medications, specific strains offer evidence-based help with the digestive side effects (constipation, bloating, and disrupted gut balance) that so often come with treatment.

What probiotics can't do is replace the medication, and any product suggesting otherwise deserves skepticism. The most sensible approach is the one the research supports: a diverse, multi-strain formula, paired with real prebiotic fiber, free of the fillers that undermine gut health, used as a supportive layer within a plan your healthcare provider oversees.

Built for Real Gut Support, Not Marketing Hype

MicroBiome Restore delivers 26 probiotic strains, 9 organic prebiotics, and 80+ trace minerals in a filler-free pullulan capsule. It delivers diversity and fiber, whether or not you're on a GLP-1.

Discover MicroBiome Restore →

References

  1. Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M. (2012). Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes, 61(2), 364–371. https://doi.org/10.2337/db11-1019
  2. Psichas, A., Sleeth, M. L., Murphy, K. G., Brooks, L., Bewick, G. A., Hanyaloglu, A. C., Ghatei, M. A., Bloom, S. R., & Frost, G. (2015). The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. International Journal of Obesity, 39(3), 424–429. https://doi.org/10.1038/ijo.2014.153
  3. Yadav, H., Lee, J.-H., Lloyd, J., Walter, P., & Rane, S. G. (2013). Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. Journal of Biological Chemistry, 288(35), 25088–25097. https://doi.org/10.1074/jbc.M113.452516
  4. Pegah, A., Abbasi-Oshaghi, E., Khodadadi, I., Mirzaei, F., & Tayebinia, H. (2021). Probiotic and resveratrol normalize GLP-1 levels and oxidative stress in the intestine of diabetic rats. Metabolism Open, 10, 100093. https://doi.org/10.1016/j.metop.2021.100093
  5. Dutta, S., Mahen, K. K., Massey, W. J., Varadharajan, V., Hazen, S. L., & Brown, J. M. (2026). Gut microbe-derived N-acyl serinol lipids shape host postprandial metabolic homeostasis. Proceedings of the National Academy of Sciences, 123(12), e2517314123. https://doi.org/10.1073/pnas.2517314123
  6. Kim, A.-R., Jeon, S.-G., Park, S.-J., Kim, B.-K., Kweon, M.-N., Jang, M. H., & Yang, B.-G. (2026). Energy-metabolism-enhancing probiotics enhance the therapeutic response to a glucagon-like peptide-1 receptor agonist. Nutrients, 18(7), 1050. https://doi.org/10.3390/nu18071050
  7. Jalleh, R. J., Plummer, M. P., Marathe, C. S., Umapathysivam, M. M., Quast, D. R., Rayner, C. K., Jones, K. L., Wu, T., Horowitz, M., & Nauck, M. A. (2024). Clinical consequences of delayed gastric emptying with GLP-1 receptor agonists and tirzepatide. The Journal of Clinical Endocrinology & Metabolism, 110(1), 1–15. https://doi.org/10.1210/clinem/dgae719
  8. Xie, X., Yang, S., Deng, S., Liu, Y., Xu, Z., & He, B. (2025). Comparative gastrointestinal adverse effects of GLP-1 receptor agonists and multi-target analogs in type 2 diabetes: A Bayesian network meta-analysis. Frontiers in Pharmacology, 16, 1613610. https://doi.org/10.3389/fphar.2025.1613610
  9. Dimidi, E., Christodoulides, S., Fragkos, K. C., Scott, S. M., & Whelan, K. (2014). The effect of probiotics on functional constipation in adults: A systematic review and meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition, 100(4), 1075–1084. https://doi.org/10.3945/ajcn.114.089151
  10. Goodoory, V. C., Khasawneh, M., Black, C. J., Quigley, E. M. M., Moayyedi, P., & Ford, A. C. (2023). Efficacy of probiotics in irritable bowel syndrome: Systematic review and meta-analysis. Gastroenterology, 165(5), 1206–1218. https://doi.org/10.1053/j.gastro.2023.07.018
  11. Gofron, K. K., Wasilewski, A., & Małgorzewicz, S. (2025). Effects of GLP-1 analogues and agonists on the gut microbiota: A systematic review. Nutrients, 17(8), 1303. https://doi.org/10.3390/nu17081303
  12. Wang, X., Chen, L., Zhang, C., Shi, Q., Zhu, L., Zhao, S., Luo, Z., & Long, Y. (2024). Effect of probiotics at different intervention time on glycemic control in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Frontiers in Endocrinology, 15, 1392306. https://doi.org/10.3389/fendo.2024.1392306
  13. Liang, T., Xie, X., Wu, L., Li, L., Yang, L., Gao, H., Deng, Z., Zhang, X., Chen, X., Zhang, J., Ding, Y., & Wu, Q. (2022). Comparative analysis of the efficacies of probiotic supplementation and glucose-lowering drugs for the treatment of type 2 diabetes: A systematic review and meta-analysis. Frontiers in Nutrition, 9, 825897. https://doi.org/10.3389/fnut.2022.825897
  14. Borgeraas, H., Johnson, L. K., Skattebu, J., Hertel, J. K., & Hjelmesæth, J. (2018). Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: A systematic review and meta-analysis of randomized controlled trials. Obesity Reviews, 19(2), 219–232. https://doi.org/10.1111/obr.12626

About BioPhysics Essentials

BioPhysics Essentials is committed to providing science-backed, filler-free supplements that support optimal gut health. Our formulations are designed with a single priority: your wellness, never manufacturing convenience.

This article is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any supplement, especially while taking a prescription medication such as a GLP-1 receptor agonist.

Nicholas Wunder profile picture

Nicholas Wunder

Learn More

Nicholas Wunder is the founder of BioPhysics Essentials. With a degree in Biology and a background in neuroscience and microbiology, he created Gut Check to cut through supplement industry marketing noise and share what the research actually says about gut health.